Roche cobas b101 Lipid Testing

Point-of-care Lipid testing with cobas® b 101

Closing the gap in cardiovascular risk prediction and therapeutic management

Roche’s cobas b 101 Lipid Panel Test, with the matching cobas b 101 analyzer, serves as a tool for cardiovascular disease risk assessment. The test determines reliable values of total cholesterol, HDL cholesterol and triglycerides in the blood. Thanks to the fast and accurate results, the test is optimal for use in the office, clinic and laboratory.

Important Notice: For healthcare professionals only.
The test may only be performed and interpreted by a physician or a person authorized by a physician. Medical laypersons may use and interpret the test incorrectly.

Importance of point-of-care (POC) Lipid testing

Atherosclerosis, the narrowing of the arteries due to the build-up of lipids, causes cardiovascular disease (CVD) events such as angina, intermittent claudication, stroke, and myocardial infarction.1

	More people die annually from CVD than from any other cause.2
	By 2030 deaths from CVD are expected tor each 23.3 million.2

Product details

• • For measurement of the lipid profile
  • Aids in the risk assessment of cardiovascular disease
  • Determination of total cholesterol, HDL cholesterol and triglycerides in the blood
  • High working safety thanks to application of the sample directly onto the disc
  • For use with the Roche cobas b 101 system
  • Sample material: capillary and venous whole blood
  • Sample volume: 19 μL
  • Measuring time: ≤ 6 minutes
  • Sample stability: 8 minutes
  • Measuring range:
    • Total cholesterol: 1.28 – 12.95 mmol/L
    • HDL cholesterol: 0.38 – 2.60 mmol/L
    • Triglycerides: 0.50 – 7.35 mmol/L

cobas® Lipid test

cobas® b 101 Lipid is used in POC or clinical laboratory settings to determine total cholesterol, high-density lipoprotein cholesterol (HDL), and triglycerides.4

	19 μL Fresh capillary blood (K2 or K3-EDTA whole blood or plasma)4
	Direct application from single finger prick4

	Shelf life 16 months at room temperature4
	Dual testing with HbA1c a

Full lipid panel results in 6 minutes with 19 μL capillary blood

Key benefits of cobas® b 101

• Easy and safe handling of samples and test discs
• Comprehensive connectivity and data management
• User-friendly, robust and service-free
• Confirmed performance with full compliance to guidelines5

References

1. Farmer, J.A., Liao, J. (2011). Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis. Curr Atheroscler Rep 13, 107–114.
2. World Health Organization (2021). Cardiovascular diseases (CVDs). Available at https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Last accessed November 2023.
3. Mach, F., Baigent, C., Catapano, A.L., et al. (2020). 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J 41, 111–188.
4. Roche Diagnostics International Ltd. cobas Lipid Panel Method Sheet Version 5.0
5. Roche Diagnostics International Ltd. cobas b 101 system Enhancing patient care at the point of need with combined HbA1c and lipid panel testing. Data on file